Australia markets open in 1 hour 56 minutes

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7900+0.0500 (+2.87%)
At close: 04:00PM EDT
1.8400 +0.05 (+2.79%)
After hours: 04:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.53M
Enterprise value -10.20M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.69
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.41

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 3-86.54%
S&P500 52-week change 3-15.36%
52-week high 313.5000
52-week low 31.6000
50-day moving average 32.2872
200-day moving average 33.6659

Share statistics

Avg vol (3-month) 3139.03k
Avg vol (10-day) 345.83k
Shares outstanding 58.1M
Implied shares outstanding 6N/A
Float 84.98M
% held by insiders 115.09%
% held by institutions 140.17%
Shares short (14 Sept 2022) 453.46k
Short ratio (14 Sept 2022) 40.37
Short % of float (14 Sept 2022) 43.35%
Short % of shares outstanding (14 Sept 2022) 40.66%
Shares short (prior month 14 Aug 2022) 453.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Oct 2017
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 325 Aug 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-39.20%
Return on equity (ttm)-98.09%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -24.89M
Net income avi to common (ttm)-23.42M
Diluted EPS (ttm)-0.3470
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.07M
Total cash per share (mrq)2.97
Total debt (mrq)337k
Total debt/equity (mrq)1.66
Current ratio (mrq)3.43
Book value per share (mrq)2.54

Cash flow statement

Operating cash flow (ttm)-23.25M
Levered free cash flow (ttm)-13.45M